AIC
CRBP icon

Ameritas Investment Company’s Corbus Pharmaceuticals CRBP Stock Holding History

Ameritas Investment Company’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33
Closed -$1.97K – 994
2021
Q1 		$1.97K Buy
+33
New +$2.17K ﹤0.01% 1929
2019
Q4 		– Sell
-9
Closed -$1K – 969
2019
Q3 		$1K Buy
+9
New +$1.57K ﹤0.01% 1550
2019
Q1 		– Sell
-33
Closed -$6K – 1124
2018
Q4 		$6K Buy
+33
New +$6.59K ﹤0.01% 1168

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Ameritas Investment Company's CRBP Position: Q2 2021 in Review

Ameritas Investment Company sold out of Corbus Pharmaceuticals (CRBP) in Q2 2021, closing a stake of 33 shares — an estimated $1.97K sold.

Ameritas Investment Company first reported a position in CRBP in Q4 2018 and held it in 3 quarters. The position peaked at $6K in Q4 2018. 98 funds tracked by Wall St. Rank hold CRBP as of Q2 2021.

  • Ameritas Investment Company reported no remaining Corbus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 33 Corbus Pharmaceuticals shares in Q2 2021, an estimated $1.97K.
  • Ameritas Investment Company first reported a position in Corbus Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Ameritas Investment Company's Corbus Pharmaceuticals position peaked at $6K in Q4 2018.
  • 98 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.